Literature DB >> 30702423

Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1-mediated translation inhibition.

Kunal D Pingale1,2, Gayatri D Kanade1,2, Yogesh A Karpe1,2.   

Abstract

Hepatitis E virus (HEV) induces interferons and regulates the induction of interferon-stimulated genes (ISGs) in the host cell. HEV infection has been shown to promote the expression of different ISGs, such as ISG15, IFIT1, MX1, RSAD2/Viperin and CxCL10, in cell culture and animal models. Interferon-induced protein with tetratricopeptide repeat 1 (IFIT1) is an ISG-encoded protein that inhibits the translation of viral RNA, having 5'-triphosphate or the mRNA lacking 2'-O-methylation on the 5'cap. In this study, we found that IFIT1 binds to HEV RNA to inhibit its translation. HEV replication is also restricted in hepatoma cells with overexpressed IFIT1. However, despite this binding of IFIT1 to HEV RNA, HEV successfully replicates in hepatoma cells in the infection scenario. In an effort to identify the underlying mechanism, we found that HEV RNA-dependent RNA polymerase (RdRp) binds to IFIT1, thereby protecting the viral RNA from IFIT1-mediated translation inhibition. RdRp sequesters IFIT1, resulting in the successful progression of viral replication in the infected cells. Thus, we discovered a distinct pro-viral role of HEV RdRp that is crucial for successful infection in the host, and propose a unique mechanism developed by HEV to overcome IFIT1-mediated host immune response.

Entities:  

Keywords:  RNA dependent RNA polymerase (RdRp); hepatitis E virus (HEV); interferon-induced protein with tetratricopeptide repeats 1 (IFIT1)

Mesh:

Substances:

Year:  2019        PMID: 30702423     DOI: 10.1099/jgv.0.001229

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.

Authors:  Kartikay Prasad; Fatima Khatoon; Summya Rashid; Nemat Ali; Abdullah F AlAsmari; Mohammad Z Ahmed; Ali S Alqahtani; Mohammed S Alqahtani; Vijay Kumar
Journal:  Int J Biol Macromol       Date:  2020-06-26       Impact factor: 6.953

Review 2.  Hepatitis E Virus Replication.

Authors:  Robert LeDesma; Ila Nimgaonkar; Alexander Ploss
Journal:  Viruses       Date:  2019-08-06       Impact factor: 5.048

Review 3.  Hepatitis E Virus: How It Escapes Host Innate Immunity.

Authors:  Sébastien Lhomme; Marion Migueres; Florence Abravanel; Olivier Marion; Nassim Kamar; Jacques Izopet
Journal:  Vaccines (Basel)       Date:  2020-07-28

4.  Vertical transmission of hepatitis E virus in pregnant rhesus macaques.

Authors:  Wenhai Yu; Xianhui Hao; Yi Li; Chenchen Yang; Yunlong Li; Zhanlong He; Fen Huang
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

5.  The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.

Authors:  Alsamman M Alsamman; Hatem Zayed
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

Review 6.  The Translational Bridge between Inflammation and Hepatocarcinogenesis.

Authors:  Sabine Gufler; Rita Seeboeck; Christoph Schatz; Johannes Haybaeck
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

Review 7.  Structural aspects of hepatitis E virus.

Authors:  Florencia Cancela; Ofelia Noceti; Juan Arbiza; Santiago Mirazo
Journal:  Arch Virol       Date:  2022-09-13       Impact factor: 2.685

8.  Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed 'Aging Cascade'.

Authors:  Thomas Schreiter; Robert K Gieseler; Ramiro Vílchez-Vargas; Ruy Jauregui; Jan-Peter Sowa; Susanne Klein-Scory; Ruth Broering; Roland S Croner; Jürgen W Treckmann; Alexander Link; Ali Canbay
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.